We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
US-based Avara Pharmaceutical Services has signed an asset purchase agreement to acquire Novartis Technical Operations’ sterile manufacturing facility for injectable medicines in Quebec, Canada.